Hannah L Kalvin

3PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 20, 2024
Impact of Financial Toxicity on Treatment Adherence and Quality of Life in Pancreatic Cancer.

Lauren E Schleimer, Emeline Aviki, Hannah L Kalvin

|May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study.

James W Smithy, Hannah L Kalvin, Fiona D Ehrich

|Apr 11, 2023
Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1.

Kimberly Loo, Hannah L Kalvin, Katherine S Panageas

Pageof 1